Hippocampal morphology in Huntington's disease, implications for plasticity and pathogenesis: The IMAGE-HD study

[1]  Takeshi Sakayori,et al.  Depression as a Prodromal Symptom of Neurodegenerative Diseases. , 2023, Journal of Nippon Medical School = Nippon Ika Daigaku zasshi.

[2]  Joong-Sun Kim,et al.  Structural Plasticity of the Hippocampus in Neurodegenerative Diseases , 2022, International journal of molecular sciences.

[3]  E. Vittinghoff,et al.  Depressive Symptoms Imputed Across the Life Course Are Associated with Cognitive Impairment and Cognitive Decline. , 2021, Journal of Alzheimer's disease : JAD.

[4]  B. Olaya,et al.  Depression as a Risk Factor for Alzheimer’s Disease: A Systematic Review of Longitudinal Meta-Analyses , 2021, Journal of clinical medicine.

[5]  A. Brickman,et al.  Olfactory impairment is related to tau pathology and neuroinflammation in Alzheimer's disease , 2020, medRxiv.

[6]  Qifang Zhang,et al.  Application of modern neuroimaging technology in the diagnosis and study of Alzheimer's disease , 2020, Neural regeneration research.

[7]  A. Feigin,et al.  Medical, Surgical, and Genetic Treatment of Huntington Disease. , 2020, Neurologic clinics.

[8]  N. Pedersen,et al.  Antidepressants and the Risk of Dementia: Appropriate Consideration of Confounding by Indication. , 2019, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[9]  J. Fernández-Ruiz,et al.  Longitudinal atrophy characterization of cortical and subcortical gray matter in Huntington’s disease patients , 2019, The European journal of neuroscience.

[10]  Stephen C. Strother,et al.  Hippocampal tail volume as a predictive biomarker of antidepressant treatment outcomes in patients with major depressive disorder: a CAN-BIND report , 2019, Neuropsychopharmacology.

[11]  Nellie Georgiou-Karistianis,et al.  Network spread determines severity of degeneration and disconnection in Huntington's disease , 2019, Human brain mapping.

[12]  C. Zelano,et al.  Characterizing functional pathways of the human olfactory system , 2019, eLife.

[13]  Hong-Li Yu,et al.  Olfactory Impairment and Hippocampal Volume in a Chinese MCI Clinical Sample , 2019, Alzheimer disease and associated disorders.

[14]  Jane S. Paulsen,et al.  Regional subcortical shape analysis in premanifest Huntington's disease , 2018, Human brain mapping.

[15]  K. Yaffe,et al.  Antidepressant Use and Cognitive Outcomes in Very Old Women , 2018, The journals of gerontology. Series A, Biological sciences and medical sciences.

[16]  Hsuan-Chia Yang,et al.  Increased Risk of Dementia in Patients with Antidepressants: A Meta-Analysis of Observational Studies , 2018, Behavioural neurology.

[17]  Nicholas C. Firth,et al.  An image‐based model of brain volume biomarker changes in Huntington's disease , 2018, Annals of clinical and translational neurology.

[18]  B. Miller,et al.  Egocentric and allocentric visuospatial working memory in premotor Huntington's disease: A double dissociation with caudate and hippocampal volumes , 2017, Neuropsychologia.

[19]  G. Hankey,et al.  Depression as a modifiable factor to decrease the risk of dementia , 2017, Translational Psychiatry.

[20]  Jane S. Paulsen,et al.  Patterns of Co-Occurring Gray Matter Concentration Loss across the Huntington Disease Prodrome , 2016, Front. Neurol..

[21]  Anantha Shekhar,et al.  Antidepressant Use in the Elderly Is Associated With an Increased Risk of Dementia , 2016, Alzheimer disease and associated disorders.

[22]  Michael I. Miller,et al.  Linking white matter and deep gray matter alterations in premanifest Huntington disease , 2016, NeuroImage: Clinical.

[23]  R. Barker,et al.  Hippocampal dysfunction defines disease onset in Huntington's disease , 2016, Journal of Neurology, Neurosurgery & Psychiatry.

[24]  P. Blier,et al.  A Prospective, Longitudinal Study of the Effect of Remission on Cortical Thickness and Hippocampal Volume in Patients with Treatment-Resistant Depression , 2015, The international journal of neuropsychopharmacology.

[25]  William H Theodore,et al.  Automated versus manual hippocampal segmentation in preoperative and postoperative patients with epilepsy , 2014, Epilepsia.

[26]  E. Giltay,et al.  Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY) , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[27]  Sachin S. Deshmukh,et al.  Functional correlates of the lateral and medial entorhinal cortex: objects, path integration and local–global reference frames , 2014, Philosophical Transactions of the Royal Society B: Biological Sciences.

[28]  S. Lehéricy,et al.  The structural correlates of functional deficits in early huntington's disease , 2013, Human brain mapping.

[29]  Jane S. Paulsen,et al.  Regionally selective atrophy of subcortical structures in prodromal HD as revealed by statistical shape analysis , 2012, Human brain mapping.

[30]  A. Hannan,et al.  Hippocampal Neurogenesis, Cognitive Deficits and Affective Disorder in Huntington's Disease , 2012, Neural plasticity.

[31]  Jane S. Paulsen,et al.  Patterns of serotonergic antidepressant usage in prodromal Huntington disease , 2012, Psychiatry Research.

[32]  Diederick Stoffers,et al.  Basal ganglia atrophy in prodromal Huntington's disease is detectable over one year using automated segmentation , 2011, Movement disorders : official journal of the Movement Disorder Society.

[33]  Stéphane Lehéricy,et al.  Clinical impairment in premanifest and early Huntington's disease is associated with regionally specific atrophy , 2011, Human brain mapping.

[34]  K. Smarr,et al.  Measures of depression and depressive symptoms: Beck Depression Inventory‐II (BDI‐II), Center for Epidemiologic Studies Depression Scale (CES‐D), Geriatric Depression Scale (GDS), Hospital Anxiety and Depression Scale (HADS), and Patient Health Questionnaire‐9 (PHQ‐9) , 2011, Arthritis care & research.

[35]  Simon J. A. van den Bogaard,et al.  Shape analysis of subcortical nuclei in Huntington's disease, global versus local atrophy — Results from the TRACK-HD study , 2011, Journal of the Neurological Sciences.

[36]  Susan Whitfield-Gabrieli,et al.  Cognitive training changes hippocampal function in mild cognitive impairment: a pilot study. , 2011, Journal of Alzheimer's disease : JAD.

[37]  P. Calabresi,et al.  Striatum–hippocampus balance: From physiological behavior to interneuronal pathology , 2011, Progress in Neurobiology.

[38]  E. McAuley,et al.  Exercise training increases size of hippocampus and improves memory , 2011, Proceedings of the National Academy of Sciences.

[39]  Dennis Velakoulis,et al.  Hippocampal pathology in individuals at ultra-high risk for psychosis: A multi-modal magnetic resonance study , 2010, NeuroImage.

[40]  M. Yücel,et al.  Alteration to hippocampal shape in cannabis users with and without schizophrenia , 2010, Schizophrenia Research.

[41]  J. John Mann,et al.  Antidepressants increase neural progenitor cells in the human hippocampus , 2009, Neuropsychopharmacology.

[42]  N. White.  Some highlights of research on the effects of caudate nucleus lesions over the past 200 years , 2009, Behavioural Brain Research.

[43]  Nicolaas I. Bohnen,et al.  Selective hyposmia in Parkinson disease: Association with hippocampal dopamine activity , 2008, Neuroscience Letters.

[44]  Erik Tryggestad,et al.  Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease , 2008, Neurobiology of Disease.

[45]  Christopher A. Ross,et al.  The antidepressant sertraline improves the phenotype, promotes neurogenesis and increases BDNF levels in the R6/2 Huntington's disease mouse model , 2008, Experimental Neurology.

[46]  R. V. D. Mast,et al.  Psychopathology in verified Huntington's disease gene carriers. , 2007, The Journal of neuropsychiatry and clinical neurosciences.

[47]  S. Benedict,et al.  Neural stem cells: implications for the conventional radiotherapy of central nervous system malignancies. , 2007, International journal of radiation oncology, biology, physics.

[48]  D. Craufurd,et al.  Psychiatric disorders in preclinical Huntington’s disease , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[49]  Martin Styner,et al.  Framework for the Statistical Shape Analysis of Brain Structures using SPHARM-PDM. , 2006, The insight journal.

[50]  C. Blakemore,et al.  Cognitive disorders and neurogenesis deficits in Huntington's disease mice are rescued by fluoxetine , 2005, The European journal of neuroscience.

[51]  D. Watson,et al.  Development and Validation of the Schedule of Compulsions, Obsessions, and Pathological Impulses (SCOPI) , 2005, Assessment.

[52]  Guillén Fernández,et al.  Interaction between the Human Hippocampus and the Caudate Nucleus during Route Recognition , 2004, Neuron.

[53]  E. Tulving.  Episodic memory: from mind to brain. , 2002, Annual review of psychology.

[54]  R. Snaith,et al.  The Hospital Anxiety And Depression Scale , 2003, Health and quality of life outcomes.

[55]  Jane S. Paulsen,et al.  Factor Analysis of the Frontal Systems Behavior Scale (FrSBe) , 2003, Assessment.

[56]  R. J. McDonald,et al.  Multiple Parallel Memory Systems in the Brain of the Rat , 2002, Neurobiology of Learning and Memory.

[57]  Jane S. Paulsen,et al.  Neuropsychiatric aspects of Huntington's disease , 2001, Journal of neurology, neurosurgery, and psychiatry.

[58]  Richard S. J. Frackowiak,et al.  Navigation-related structural change in the hippocampi of taxi drivers. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[59]  C. Pantelis,et al.  Hippocampal volume in first-episode psychoses and chronic schizophrenia: a high-resolution magnetic resonance imaging study. , 1999, Archives of general psychiatry.

[60]  Jane S. Paulsen,et al.  Unified Huntington's disease rating scale: Reliability and consistency , 1996, Movement disorders : official journal of the Movement Disorder Society.

[61]  R. J. McDonald,et al.  Parallel information processing in the water maze: evidence for independent memory systems involving dorsal striatum and hippocampus. , 1994, Behavioral and neural biology.

[62]  F Andermann,et al.  Anatomic basis of amygdaloid and hippocampal volume measurement by magnetic resonance imaging , 1992, Neurology.

[63]  R. Ferrante,et al.  Neuropathological Classification of Huntington's Disease , 1985, Journal of neuropathology and experimental neurology.

[64]  Paul Shaman,et al.  University of pennsylvania smell identification test: A rapid quantitative olfactory function test for the clinic , 1984, The Laryngoscope.

[65]  Yi Leng Fung,et al.  Comparative Utility of Manual versus Automated Segmentation of Hippocampus and Entorhinal Cortex Volumes in a Memory Clinic Sample. , 2019, Journal of Alzheimer's disease : JAD.

[66]  R. Roos,et al.  Grey matter volume loss is associated with specific clinical motor signs in Huntington's disease. , 2018, Parkinsonism & related disorders.

[67]  N. Muirhead.  Pennsylvania Smell Identification Test (UPSIT) Valid for the UK Population , 2013 .

[68]  Jane S. Paulsen,et al.  Regional atrophy associated with cognitive and motor function in prodromal Huntington disease. , 2013, Journal of Huntington's disease.

[69]  Martin Styner,et al.  Hippocampal shape analysis in Alzheimer's disease and frontotemporal lobar degeneration subtypes. , 2012, Journal of Alzheimer's disease : JAD.

[70]  A. Brickman,et al.  Depressive symptoms, antidepressant use, and brain volumes on MRI in a population-based cohort of old persons without dementia. , 2012, Journal of Alzheimer's disease : JAD.

[71]  D. Craufurd,et al.  Longitudinal evaluation of neuropsychiatric symptoms in Huntington's disease. , 2012, The Journal of neuropsychiatry and clinical neurosciences.

[72]  Jane S. Paulsen,et al.  Neurocognitive signs in prodromal Huntington disease. , 2011, Neuropsychology.

[73]  G. MacQueen,et al.  A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. , 2009, Journal of psychiatry & neuroscience : JPN.

[74]  R. Doty,et al.  The University of Pennsylvania Smell Identification Test: normative adjustment for Australian subjects , 2001 .

[75]  J. Stroop.  Studies of interference in serial verbal reactions. , 1992 .